ROCKWELL MEDICAL, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ROCKWELL MEDICAL, INC. (RMTI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.01M shares, a 5.06% decline year-over-year.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.38M shares, a 35.79% increase year-over-year.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 10.56M shares, a 159.79% increase year-over-year.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.06M shares, a 75.47% decline year-over-year.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 10.54M shares, a 34.33% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.85M shares, a 16.33% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.75M shares, a 47.68% decline from fiscal 2022.
- ROCKWELL MEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 12.89M shares, a 334.47% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.01M shares 10-Q · filed 2026-08-13 | 1.01M shares 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | 10.38M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 10.54M shares 10-K · filed 2026-03-26 | |||||||
| 2025-09-30 | 10.56M shares 10-Q · filed 2025-11-12 | 10.56M shares 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | 1.06M shares 10-Q · filed 2026-08-13 | 10.62M shares 10-Q · filed 2025-08-14 | 1.06M shares 10-Q · filed 2026-08-13 | 10.62M shares 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | 7.64M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 7.85M shares 10-K · filed 2026-03-26 | |||||||
| 2024-09-30 | 4.06M shares 10-Q · filed 2025-11-12 | 4.08M shares 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | 4.33M shares 10-Q · filed 2025-08-14 | 7.78M shares 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | 7.67M shares 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | 6.75M shares 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | 7.06M shares 10-Q · filed 2024-11-12 | 7.06M shares 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | 13.44M shares 10-Q · filed 2024-08-08 | 13.44M shares 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | 12.88M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 12.89M shares 10-K · filed 2024-03-21 | 19.19M shares 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | 20.31M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 14.22M shares 10-Q · filed 2023-08-14 | 23.27M shares 10-Q · filed 2022-08-15 | ||||||
| 2022-03-31 | 2.94M shares 10-Q · filed 2023-05-15 | 2.94M shares 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | 2.97M shares 10-K · filed 2023-03-30 | 32.64M shares 10-K · filed 2022-04-08 | ||||||
| 2021-09-30 | 2.97M shares 10-Q · filed 2022-11-14 | 32.72M shares 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | 2.99M shares 10-Q · filed 2022-08-15 | 32.92M shares 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | 2.99M shares 10-Q · filed 2022-05-16 | 32.89M shares 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | 33.31M shares 10-K · filed 2022-04-08 | |||||||
| 2020-09-30 | 33.50M shares 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | 10.12M shares 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | 13.05M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | 12.97M shares 10-K · filed 2021-03-31 | |||||||
| 2019-09-30 | 12.41M shares 10-Q · filed 2020-11-09 | |||||||
| 2019-06-30 | 12.76M shares 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 9.90M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 12.62M shares 10-K · filed 2020-03-17 | 9.85M shares 10-K · filed 2019-03-18 | ||||||
| 2018-09-30 | 9.49M shares 10-Q · filed 2019-11-12 | 9.34M shares 10-Q · filed 2018-11-09 | ||||||
| 2018-06-30 | 6.88M shares 10-Q · filed 2018-08-14 | 7.29M shares 10-Q · filed 2019-08-09 | 6.81M shares 10-Q · filed 2018-08-14 | |||||
| 2018-03-31 | 7.36M shares 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | 7.39M shares 10-K · filed 2019-03-18 | |||||||
| 2017-09-30 | 7.81M shares 10-Q · filed 2018-11-09 | |||||||
| 2017-06-30 | 7.71M shares 10-Q · filed 2018-08-14 | 7.71M shares 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |